• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL CANADA, INC.; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL CANADA, INC.; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A-IDE
Device Problems Material Too Rigid or Stiff (1544); Device Operates Differently Than Expected (2913)
Patient Problems Aortic Regurgitation (1716); Congestive Heart Failure (1783)
Event Date 06/24/2016
Event Type  Injury  
Manufacturer Narrative
Gtin -- unavailable as device was manufactured prior to gtin assignment.
 
Event Description
On (b)(6) 2009, a 23mm trifecta valve was implanted.On (b)(6) 2016, the patient presented with acute congestive heart failure.Further evaluation showed severe aortic regurgitation secondary to presumed valve deterioration and a flail cusp which led to the valve being explanted the same day.Intraoperatively, the native annulus was debrided and was found to be stiff and noncompliant.A 21mm edwards magna ease valve was implanted.(clinical patient study id: (b)(6)).
 
Manufacturer Narrative
The results of this investigation concluded tearing was observed in all three cusps, with loss and denaturation of collagen at the tear sites.Circumferential fibrous pannus ingrowth was observed on the inflow side with minimal extension onto cusp 1, and protrusion into the inflow space and mild narrowing of inflow diameter.Cusp 3 was mildly fibrotically thickened.No acute inflammation or significant calcifications was observed.No evidence was found to suggest the cause of the cusp tears, pannus, loss and denaturation of collagen, and fibrous thickening was due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6 L7
CA  J2S 6L7
Manufacturer (Section G)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6 L7
CA   J2S 6L7
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5783411
MDR Text Key49203158
Report Number8020430-2016-00010
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/24/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date09/30/2009
Device Model NumberTF-23A-IDE
Device Catalogue NumberTF-23A-IDE
Device Lot Number2777336
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/29/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/24/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-